Authors


Nicodemo Nick Calla, RPh, JD

Latest:

Specialty Pharmacists Play a Vital Part in the Treatment of Hepatitis C

Pharmacists provide medication expertise that is essential to both the patient and the health care team in the treatment of hepatitis C.


Andrew Styperek, MD, MBA

Latest:

Malignant Melanoma: The Implications of Cost for Stakeholder Innovation

An activity-based cost accounting model of melanoma care was used to identify key cost drivers and opportunities for stakeholder innovation.


Steven M. Fox, CPA

Latest:

Generational Impact on Prescription Drug Trend: Part 2

This retrospective study of 558.9 million prescription claims explores how member age demographics affect prescription drug trends and provides top therapeutic classes by generation.




Victoria Pho, PharmD, BCGP

Latest:

The 7 Habits of Highly Effective Pharmacy Students and Interns

Can we teach effective habits? Is there a blueprint for helping pharmacy students and interns be more proactive, prioritize more efficiently, and embrace a strong work ethic?


Khai Phan, PharmD Candidate

Latest:

Successful Implementation of Student-Driven Virtual Transitions of Care Model During the COVID-19 Pandemic

Virtual transitions of care services are a valuable and viable opportunity for students to progress to graduation and gain valuable experience in preparation for professional employment.


Prina Donga, MS

Latest:

Costs of Collagenase Clostridium Histolyticum and Fasciectomy for Dupuytren's Contracture

A retrospective cohort analysis was conducted to compare disease-specific healthcare resource utilization and the costs of collagenase clostridium histolyticum and fasciectomy among adult Dupuytren’s contracture patients.


Mel Seabright, PharmD, MBA

Latest:

Thoughts About CVS Health and Aetna

CVS Health has reportedly placed a bid to buy Aetna, one of the nation’s largest health insurers.


Magdalena Bryk-Gandera, BS

Latest:

Cycloset® (bromocriptine mesylate) Tablets: A Novel Treatment for the Management of Type 2 Diabetes in Adults

Cycloset (quick-release formulation of bromocriptine mesylate), a dopamine D2 agonist, is a novel agent recently approved by the FDA for type 2 diabetes mellitus.



Javier Coindreau, MD

Latest:

Pharmacists: Pivotal Players in the Biosimilars Treatment Paradigm

An understanding of biosimilars will be essential for patient consults and education.


D. Scott Momrow, MPH

Latest:

The Comparative Value of 3 Electronic Sources of Medication Data

Combining medication history information from multiple sources improves the completeness and accuracy of the medication information.


Linda Truong, PharmD

Latest:

Change Together for the Better

As we grow and mature, our thoughts and opinions inevitably change as we gain experience and wisdom.



Jonathan St. Onge, PharmD

Latest:

Going Back to Get Ahead: Transitioning from Pharmacist to Pharmacy Resident

Graduating from pharmacy school is significant milestone for pharmacists, as it marks their long-awaited transition from student to professional and the beginning of their career.


Jessica Langley, MS

Latest:

How Pharmacy Technicians Can Be Certified to Administer Immunizations in 2020

Pharmacy technicians are garnering support from key industry leaders as they rally for more active roles and responsibility.


Mitchell DeKoven, MHSA

Latest:

Costs of Collagenase Clostridium Histolyticum and Fasciectomy for Dupuytren's Contracture

A retrospective cohort analysis was conducted to compare disease-specific healthcare resource utilization and the costs of collagenase clostridium histolyticum and fasciectomy among adult Dupuytren’s contracture patients.


Christopher A. Bly, BA

Latest:

Cost-Effectiveness of Live Attenuated Versus Inactivated Influenza Vaccine Among Children

Vaccination with trivalent live attenuated versus inactivated influenza vaccine in children aged 2 to 17 years is cost saving or cost-effective depending on the severity of the influenza season.



Stephanie L. Freed, PharmD

Latest:

Raising the Bar Through Education and Quality Initiatives

From its creation, Diplomat University at Diplomat Specialty Pharmacy has been structured around its primary objective to provide a high-level of ongoing education to enable staff and partners to take the best possible care of patients.


Kiernan Taylor & Rachel Jennings, PharmD Candidates

Latest:

How Diet and Lifestyle Modifications Can Improve Cognitive Function in the Elderly

Select foods, vitamins, and cardiovascular activity have all been proven in clinical literature to be essential components of improving the health of our encephala.


Aileen Ahiskali, PharmD, BCIDP

Latest:

Choose the Most Appropriate Therapy to Fight Influenza

Baloxavir marboxil and oseltamivir are options for treating uncomplicated influenza.


Eleanor Hayes-Larson, MPH

Latest:

Daily Dose and Costs of Therapy With Topical Testosterone Agents

We assessed time to maintenance dose attainment in commercially insured men initiating topical testosterone agents and compared daily maintenance doses and costs of this therapy.


Jipan Xie, MD, PhD

Latest:

Cost Impact of Switching From Metoprolol to Nebivolol for Hypertension

A large single-payer administrative claims database was used to assess the economic impact of switching from metoprolol to nebivolol for the treatment of hypertension.


With Theresa Tolle, DeAnn Mullins

Latest:

Women at the Forefront of Pharmacy

Three female leaders in pharmacy discuss the changes in this industry.


Taylor R. Elliot, PharmD/MPH candidate

Latest:

COVID-19 and Telehealth: Will the Expansion Persist After the Pandemic?

A temporary public policy change and insurers' expanded benefits have allowed the growth of telehealth services during the COVID-19 pandemic.


Amanda Manoogian, PharmD, BCOP, Clinical Pharmacy Coordinator Specialty Pharmacy - Clinical Services (Partners Healthcare)

Latest:

Oral Therapies for Hormone Receptor – Positive Breast Cancers

The recent development of cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors, as well as alpelisib (Piqray), a phosphoinositide 3-kinase (PI3K) inhibitor, has changed the way patients with HR-positive MBC are treated.